The /Mactamases of six strains of Acinetobacter baumannii were investigated using analytical isoelectric focusing, and the MIC values for 16 /J-lactam antibiotics determined against the strains. Three strains produced a chromosomal cephalosporinase (pi > 8.5), one strain a CARB-5 /?-lactamase (pi = 6.35), one strain a TEM-1 penicillinase (pi = 5.4) as well as a cephalosponnase (pi > 8.5), and one carbapenem-resistant strain a /i-lactamase with a pi > 8.5. Ceftazidime, cefepime, cefpirome, imipenem and meropenem were found to be the most effective /Mactams against five strains. Sulbactam was active against four of the strains at \-4 mg/L and showed enhanced killing effects with cefpirome.
Introduction
Acinetobacter baumannii is one of the most important species responsible for nosocomial infections, particularly in intensive care units (ICU) (Hartstein et al., 1988) . Strains isolated in ICU are increasingly resistant to antibiotics. From November 1992 to March 1993 we observed an outbreak in the ICU of Bellevue Hospital (Saint-Etienne, France). The epidemic strain presented a high level of resistance to antibiotics (Aubert et al., 1994) . The aim of this study was to investigate six clinical strains of A. baumannii of the main phenotypes isolated in France. We determined the MIC of 16 /Mactams, as well as the isoelectric point (pi) of /Mactamase and /?-lactamase activity. Bacteriostatic and bactericidal activity of some cephalosporins were evaluated alone and in combination with either amikacin or sulbactam.
Materials and methods

Bacterial strains
Six clinical bacteria strains (defined as Dl to D6 in this study) were identified as A. baumannii by morphology, a cytochrome oxidase test, glucose fermentation, growth at 44°C and an API 20 NE system (API bioMerieux, La Balme les Grottes, France). These strains were isolated from cerebrospinal fluid, blood culture and 
Antibiotics and inhibitors tested
The following antibiotics were tested: amoxycillin and ticarcillin (Smithkline Beecham), piperacillin (Lederle), cefotaxime and cefpirome (Roussel), ceftazidime (Glaxo), ceftriaxone (Roche), aztreonam, amikacin and cefepime (Bristol-Myers Squibb), cefoxitin and imipenem (M.S.D.), cefotetan and meropenem (Zeneca-Pharma), cephalothin, latamoxef (Lilly), ciprofloxacin (Bayer-Pharma) and mecillinam (Leo). /Mactamase inhibitors tested were: clavulanic acid (SmithKline Beecham), tazobactam (Lederle) and sulbactam (Pfizer).
MIC determinations
MICs were determined by the agar dilution method on Mueller-Hinton medium (Diagnostics Pasteur, France) containing a serial two-fold dilution of antibiotics as described in a previous publication (Aubert et al., 1994) . Amoxycillin and ticarcillin were tested alone and by adding clavulanic acid at a final concentration of 2 mg/L. Piperacillin was tested alone and in combination with tazobactam at a final concentration of 4 mg/L. Beta-lactams were tested alone and in combination with sulbactam at a final concentration of 8 mg/L.
Killing curves
These experiments were performed in glass tubes, each containing 10 mL of Mueller-Hinton broth. An overnight culture in Mueller-Hinton medium was diluted with fresh broth to about 10 4 CFU/mL, and the culture was incubated for 4 h at 37 r C with shaking. Antibiotic was added to the culture at various concentrations around the MIC. 0.1 mL of the culture was removed at fixed times (1, 2, 4, 6 and 24 h) and plated on to drug-free Mueller-Hinton agar after being suitably diluted. The number of colonies was counted after 18 h incubation at 37 C and the results plotted on semilogarithmic graph paper.
lodometric test
/?-Lactamase activity was determined in cell-free extracts of the six strains using an iodometric procedure (Paul et al., 1989) . It was performed in agar (bioMerieux) at 37 C C with benzylpenicillin (1 IHM) as the substrate. This allowed differentiation between cephalosporinase-producing strains (/Mactamase inhibition by 0.1 mM cloxacillin) and penicillinase-producing strains (/Mactamase inhibition by 0.1 mM clavulanic acid).
Isoelectric focusing and fi-lactamase detection
/?-Lactamases were purified from crude extracts of cultures of the six strains. Isoelectric focusing was performed in polyacrylamide gels (acrylamide 7%, Kodak) containing 4% ampholines (LKB) with pH range of 3.3 to 9.5. The /Mactamase activity was located on the gels by an iodine-starch agar procedure (Paul et al., 1989) . The isoelectric point (pi) of the enzyme was determined using reference /Mactamases: TEM-1 (Rill), TEM-2 (RP4), TEM-4 (pUD16), CTX-1 (pCFF04).
Results
Bacteriostatic effect of antibiotics and inhibitors
The results of MIC determinations are given in the Table. Sulbactam had good activity against four of the strains, with MIC values of 1-4 mg/L. Three strains (Dl, D2, D3) produced a chromosomal cephalosporinase and were sensitive to ticarcillin. Strain D6 produced a CARB-5 /Mactamase and was highly resistant to ticarcillin. Strains D4 and D5 were less sensitive. The other two inhibitors, clavulanic acid and tazobactam, had a modest degree of activity with strain D4 again being the least sensitive.
The most active compounds against all six strains were the carbapenems imipenem and meropenem, although strain D4 showed the least sensitivity (MICs 8 mg/L for imipenem and 32 mg/L for meropenem). Ceftazidime, cefepime and cefpirome were the most active of the cephalosporins with good activity against strains Dl, D2 and D6. Strains D3 and D5 were less sensitive, and D4 had poor sensitivity to all compounds tested.
Clavulanic acid had no effect on the activity of amoxycillin or ticarcillin, and tazobactam had no effect on the activity of piperacillin, except against strain D6, where it was active in its own right. Sulbactam had no effect on the activity of any of the compounds against the resistant strains D4 and D5, other than a marginal reduction in the MIC of aztreonam against D4. It was active alone at 8 mg/L, the concentration used in the combination MIC tests, against the other four strains.
Bactericidal effect of fl-lactams with and without sulbactam
Although having an inhibitory effect, no bactericidal effect was observed with sulbactam alone (2-64 mg/L) for strains Dl, D2, D3 and D6. A bactericidal effect (4 log, 0 decrease) of ceftazidime, cefpirome and cefepime was observed after 24 h using 8 x MICs for strains Dl, D2, D3 and D6. Synergistic interaction was observed after 24 h between sulbactam (8 and 16 mg/L) and ceftazidime (2 x MIC), cefpirome (2 x MIC), or cefepime (2 x MIC) for the four strains Dl, D2, D3 and D6. Time killing-curves are given only for cefepime and cefepime-sulbactam for D6 (Figure) . Bactericidal activity of the combination of amikacin (2 x MIC) and ceftazidime (2 x MIC), cefpirome (2 x MIC), or cefepime (2 x MIC) was observed after 1 or 2 h for Dl and D6 strains (data not shown). 
fi-Lactamase cell assays
We observed 4 strains (Dl, D2, D3 and D5) with a chromosomal cephalosporinase (pi > 8.5). Two of these produced another /Mactamase: strain Dl produced a /Mactamase with a pl = 7.9 and D5 a TEM-1 penicillinase (pi = 5.4). A carbapenem-resistant strain (D4) produced a /Mactamase with a pi > 8.5. This /Mactamase was not inhibited by clavulanic acid or cloxacillin. The D6 strain produced a CARB-5 /Mactamase (pi = 6.35). We did not study the outer membrane of these strains.
Discussion
The major problem related to the A. baumannii species in multiresistance of isolates which may lead to a therapeutic dilemma (strains D3, D4 and D5) (Joly-Guillou et al., 1988; Seifert et al., 1993; Traub & Spohr, 1993) . Six phenotypes were defined: Dl to D6. In terms of MIC, the most active agents against A. baumannii were imipenem and meropenem. A superior bacteriostatic and bactericidal effect (data not shown) was seen when (8 and 16 mg/L) sulbactam was added to carbapenems.
In France, few strains were reported as being resistant to imipenem which often remains the only effective treatment.
Three of the strains, Dl, D2 and D6, were moderately sensitive to amikacin (MIC 2-4 mg/L) and for these strains, the greatest bactericidal effects were seen with a combination of amikacin and methoxyimino cephalosponns. The remaining three strains were resistant to amikacin and the addition of cephalosponns had no significant effect (data not shown). For strain D3, we noted a bactericidal effect for the combination of cefepime (ceftazidime, cefpirome) plus sulbactam. D3 was the aetiological agent of the outbreak in the intensive care unit of Bellevue Hospital from November 1992 to March 1993. Of 15 patients affected, three were cured with this combination during the outbreak. The other patients were treated with imipenem. Sulbactam has poor inhibitor activity against cephalosporinase but shows an intrinsic activity against A. baumannii (Labia etal., 1986) . Sulbactam has an affinity for penicillin-binding protein 2 (Labia et al., 1986; Retsema et al., 1986) . The concentration of 8 or 16 mg/L of sulbactam is easily obtained in vivo. After intravenous infusion of 1 g of sulbactam, serum concentrations of sulbactam remain above 8 mg/L for 3 hours (Foulds et al., 1985) .
When strains are susceptible to ticarcillin (MIC < 64 mg/L) or produce CARB-5, sulbactam can be combined with /Mactam. However, CARB-5 penicillinase is rarely observed in clinical isolates. The strain which had a TEM-1 /Mactamase presented a low susceptibility for sulbactam (MIC = 16 mg/L for strain D5). TEM-1 /Mactamase is more often present in clinical strains. Kitsis et al. (1983) demonstrated MICs of 8 or 16 mg/L for sulbactam when Acinetobacter calcoaceticus was carbenicillin-resistant. In their study, in the presence of clavulanic acid (5-10 mg/L), the MIC of sulbactam for all carbenicillin-resistant strains decreased to less than 4 mg/L.
Sulbactam has low toxicity and it can be combined with certain /Mactams. It cannot be prescribed alone as an antibiotic because it has bacteriostatic activity only against A. baumannii. Ceftazidime, cefepime and cefpirome have better bacteriostatic activity than cefotaxime, ceftriaxone and latamoxef. High doses of methoxyimino cephalosporins and sulbactam must be used against strains producing high levels of cephalosporinase (strain D3) and resistant to aminoglycosides. This combination can be used as an alternative to carbapenem treatment.
